Detection of high-risk subjects in acute myocardial infarction (AMI) by noninvasive means
would reduce the need for intracardiac catheterization and associated complications. Liver
enzymes are associated with cardiovascular disease risk. A potential predictive value for
liver serum markers for the severity of stenosis in AMI was analyzed.